These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 6421755)
41. Uses of blood and of blood components. Med Lett Drugs Ther; 1972 Nov; 14(24):89-92. PubMed ID: 4648571 [No Abstract] [Full Text] [Related]
42. [Effect of plasmapheresis on immunoglobulin levels in blood donors]. Yokoyama S; Matsuura N; Saji H; Hosoi T Rinsho Ketsueki; 1986 Jul; 27(7):1238-41. PubMed ID: 3784002 [No Abstract] [Full Text] [Related]
43. Influence of long-term plasmapheresis on blood coagulation. Grgicević D Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088 [TBL] [Abstract][Full Text] [Related]
44. [Blood and fractionation of blood]. Soeterboek AM Pharm Weekbl; 1969 Dec; 104(50):1578-601. PubMed ID: 4188429 [No Abstract] [Full Text] [Related]
45. A perspective of Soviet blood banking. Cohen E Transfusion; 1974; 14(4):315-27. PubMed ID: 4210518 [No Abstract] [Full Text] [Related]
46. [Electrophoretic control of serum proteins in donors designated for plasmapheresis. Initial evaluation of the analysis of 3500 donors]. Fine JM; Marneux M; Sayarath V Rev Fr Transfus Immunohematol; 1985 May; 28(2):125-36. PubMed ID: 4023543 [TBL] [Abstract][Full Text] [Related]
47. [A possibility of production of plasma fraction I in a blood donor service]. GAERISCH F; STEIN P Z Gesamte Inn Med; 1963 Jan; 18():17-20. PubMed ID: 13946074 [No Abstract] [Full Text] [Related]
48. Current plasmapheresis practice in the United States. Tullis JL Ric Clin Lab; 1983; 13(1):11-9. PubMed ID: 6344176 [TBL] [Abstract][Full Text] [Related]
49. Recent advances in the practice and technology of blood transfusion. Sandler SG Prim Care; 1980 Sep; 7(3):347-67. PubMed ID: 6777791 [No Abstract] [Full Text] [Related]
50. Plasma exchange donation of cryoprecipitate after DDAVP stimulation: an alternative source of factor VIII. McLeod BC; Scott JP Prog Clin Biol Res; 1990; 324():189-98. PubMed ID: 2106687 [TBL] [Abstract][Full Text] [Related]
51. Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines. Cheraghali AM; Aboofazeli R Transfus Med; 2009 Dec; 19(6):363-8. PubMed ID: 19778319 [TBL] [Abstract][Full Text] [Related]
52. A prospective trial on the safety of long-term intensive plasmapheresis in donors. Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729 [TBL] [Abstract][Full Text] [Related]
53. Current plasmapheresis practices in the United States. Crispen JF Dev Biol Stand; 1980; 48():297-301. PubMed ID: 7274561 [No Abstract] [Full Text] [Related]
54. 'Vampire syndrome': serum protein and lipid abnormalities related to frequent sale of plasma. Jones DK; Dunn MI J Fam Pract; 1995 Mar; 40(3):288-90. PubMed ID: 7876787 [TBL] [Abstract][Full Text] [Related]
55. Logistics of automated plasma collection. McCombie N; Rock G J Clin Apher; 1988; 4(2-3):104-7. PubMed ID: 3397371 [TBL] [Abstract][Full Text] [Related]
56. The role of commercial plasmapheresis banks on the AIDS epidemic in Mexico. Volkow P; Perez-Padilla R; del-Rio C; Mohar A Rev Invest Clin; 1998; 50(3):221-6. PubMed ID: 9763887 [TBL] [Abstract][Full Text] [Related]
57. [Blood products and plasma derivatives]. Faber JC Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):45-53. PubMed ID: 3242960 [No Abstract] [Full Text] [Related]
58. Factor VIII preservation following collection into commercial plasmapheresis systems. Mishler JM; Nicora RW; Hamilton JE; Caster G; Kasper CK Transfusion; 1975; 15(4):377-9. PubMed ID: 1166510 [TBL] [Abstract][Full Text] [Related]
59. The development of plasma derivatives in Australia. Schiff P Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156 [No Abstract] [Full Text] [Related]